Amgen's global Phase III DeLLphi-304 trial of Imdelltra (tarlatamab-dlle) has met its primary endpoint at a planned interim ...

First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy, for Patients With Progression On or After Platinum-Based Chemotherapy ...

Imdelltra is associated with improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell lung cancer.

King family opposes release of classified documents on King's assassination, citing privacy concerns and potential harm to ...

Nearly a year after winning an accelerated approval for its DLL3-targeting small cell lung cancer (SCLC) therapy Imdelltra, ...

Amgen (NasdaqGS:AMGN) made considerable strides in its oncology portfolio, as evidenced by the successful interim results for ...

DNI Tulsi Gabbard said Thursday that the assassination files of Martin Luther King Jr. and Robert F. Kennedy would be released in "the next few days." ...

WASHINGTON, D.C. - The Lawyer’s Committee for Civil Rights Under Law has filed a brief here April on behalf of the Southern ...

David Spigel, MD, discusses the significant benefits of durvalumab as consolidation therapy following standard ...

ST-001, an intravenous nanoformulation of fenretinide, will be evaluated in a phase 1a/1b small cell lung cancer trial.

In a small study, lactotransferrin (LTF) was identified as a potentially important biomarker in extensive-stage small cell ...

The Chamber of Commerce of West Alabama’s Adopt-A-School Program connects local businesses and organizations with schools in ...